Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
DBC-664 in Locally Advanced Malignant Solid Neoplasm: NCT07705035 Clinical Landscape Report 2026
16 September 2026
NCT07705035 clinical landscape for Locally Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development w…
9 min read
LC autologous blood origin T lymphocyte in Hepatocellular Carcinoma: NCT07709299 Clinical Landscape Report 2026
16 September 2026
NCT07709299 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lenalidomide in Multiple Myeloma: NCT07709884 Clinical Landscape Report 2026
16 September 2026
NCT07709884 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ZR001 in Parkinson Disease: NCT07718659 Clinical Landscape Report 2026
16 September 2026
NCT07718659 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Prednisolone in Lupus Nephritis: NCT07719140 Clinical Landscape Report 2026
16 September 2026
NCT07719140 clinical landscape for Lupus Nephritis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Betamethasone in Dermatitis, Atopic: NCT07713186 Clinical Landscape Report 2026
16 September 2026
NCT07713186 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tumor antigen-pulsed autologous dendritic cells (Chang Gung Memorial Hospital) in Advanced Hepatocellular Carcinoma: NCT07726329 Clinical Landscape Report 2026
16 September 2026
NCT07726329 clinical landscape for Advanced Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Revefenacin in Pulmonary Disease, Chronic Obstructive: NCT07721922 Clinical Landscape Report 2026
16 September 2026
NCT07721922 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
Roflumilast in Psoriasis of nail: NCT07725822 Clinical Landscape Report 2026
16 September 2026
NCT07725822 clinical landscape for Psoriasis of nail: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Iberdomide in Relapse multiple myeloma: NCT07727668 Clinical Landscape Report 2026
16 September 2026
NCT07727668 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CD30.CAR-EBVST cell therapy(Baylor College of Medicine) in Hodgkin's Lymphoma: NCT07729397 Clinical Landscape Report 2026
16 September 2026
NCT07729397 clinical landscape for Hodgkin's Lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
MTAI-1025 in Digestive System Disorders: ACTRN12626000920392 Clinical Landscape Report 2026
16 September 2026
ACTRN12626000920392 clinical landscape for Digestive System Disorders: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…